Latest News & Updates

Breaking News

  • 3 hours ago

  • Pharma Now Editorial Team

Anupam Rasayan Acquires 43.3–48.2% Stake in Bliss GVS Pharma in Vertical Integration Move
Breaking News
AbbVie Gains EU Committee Backing for MAVIRET Expansion into Acute Hepatitis C Indication

Pharma Now Editorial Team

Other trending news you may like to read

Anupam Rasayan Acquires 43.3–48.2% Stake in Bliss GVS Pharma in Vertical Integration Move

Anupam Rasayan acquires a 43.3–48.2% stake in Bliss GVS Pharma, raising GMP alignment and regulatory integration questions for the combined entity.

Pharma Now Editorial Team

Pharma Now

AbbVie Gains EU Committee Backing for MAVIRET Expansion into Acute Hepatitis C Indication

AbbVie's MAVIRET receives CHMP positive opinion for acute HCV, potentially creating one of the EU's few dual acute/chronic hepatitis C labels.

Pharma Now Editorial Team

Pharma Now

Lilly's Foundayo Achieves Significant Weight Reduction in Seniors Across All Doses at 72 Weeks

Lilly's Foundayo hit statistically significant weight loss across all doses at 72 weeks, raising CMC and scale-up stakes for oral GLP-1 competitors.

Pharma Now Editorial Team

Pharma Now

Merck Gains CHMP Positive Opinion for KEYTRUDA Combo in Bladder Cancer Indication

CHMP backs Merck's KEYTRUDA combo for bladder cancer; European Commission decision expected Q3 2026.

Pharma Now Editorial Team

Pharma Now